ILK-IN-2 is primarily used in biomedical research as a potent inhibitor of integrin-linked kinase (ILK). This compound is valuable in studying cellular signaling pathways, particularly those involved in cell adhesion, migration, and survival. Researchers utilize ILK-IN-2 to investigate its effects on cancer progression, as ILK plays a role in tumor growth and metastasis. It is also employed in exploring potential therapeutic strategies for diseases where ILK activity is dysregulated, such as fibrosis and cardiovascular disorders. Additionally, ILK-IN-2 aids in understanding the molecular mechanisms underlying tissue development and repair processes. Its application extends to drug discovery efforts aimed at targeting ILK-related pathways for therapeutic interventions.